|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / November 2008 / November 1, 2008 Bone-building find hold hope for improved osteoporosis treatment |
Obesity has no major impact on ovarian cancer survival: Study
Five tips on how to stick with resolutions
Archaeologists use satellites to unearth Egypts ancient ruins
Sack lunches may not provide adequate nutrients to preschooler
Packing lunch for your child might not be a good idea, for a new study has found that sack lunches may not regularly provide adequate nutrients for the growth and development of young children. ANI
Health-monitoring system helps maintain older adults well-being
Many older adults want to remain active and independent for as long as possible. Now, researchers from University of Missouri suggest that installing health monitoring system can help keep check on the health of the elderly and ensure their privacy. ANI
New drug shows potential to treat angina, other cardiac problems
A compound, designed to prevent chest pains in heart patients, could act as a drug to treat angina and possibly other cardiac pathologies, according to a study on animals. ANI
A team of American scientists claims to have uncovered an important step in hormone-triggered bone growth, paving the way for new osteoporosis drugs and better bone-building therapies.
Washington, November 1 : A team of American scientists claims to have uncovered an important step in hormone-triggered bone growth, paving the way for new osteoporosis drugs and better bone-building therapies.
The research from the University of Alabama at Birmingham (UAB) showed that parathyroid hormone (PTH) given intermittently enhances the body's own bone-building action through a specific "co-receptor" on the surface of bone cells.
While scientists have known for long that PTH stimulates bone formation, the exact mechanism underlying this effect has been unknown to date.
"Our study uncovers a novel mechanism for how parathyroid hormone signaling selectively stimulates bone formation. We have identified the protein co-receptor crucial to the whole process," said Dr. Xu Cao, UAB professor of pathology and senior author on the study.
During the study, the researchers focused on PTH signals in mice to see which cell receptors would actively recruit calcium from the blood.
Dr. Mei Wan, UAB associate professor of molecular and cellular pathology and first author on the study, said that the team's efforts helped uncover the one co-receptor responsible for turning on bone building.
Dr. Jay McDonald, pathology professor and director of UAB's Center for Metabolic Bone Disease, pointed out that the exact mechanism of PTH-signalled bone formation was previously shrouded by the joint production of osteoblasts and osteoclasts, two types of cells that are instrumental in regulating a healthy skeleton.
While osteoblasts regulate a healthy skeleton by forming new bone, and osteoclasts do so by resorbing old and brittle bone.
McDonald highlighted the fact that many existing osteoporosis drugs target both osteoblasts and osteoclasts, which can lead to zero or minimal bone formation.
"The ideal would be to have one drug to shut down the osteoclasts and turn on the osteoblasts to effectively build bone. We don't have that yet, but this study shows us the path to get there," he said.
An article describing the new study has been published in the journal Genes and Development.
ANI
